Cargando…
Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain
Epilepsy is considered as a common and diverse set of chronic neurological disorders and its symptoms can be controlled by antiepileptic drugs (AEDs). The presence of p-glycoprotein and multi-drug resistance transporters in the blood-brain barrier could prevent the entry of AEDs into the brain, caus...
Autores principales: | Liu, Shanshan, Yang, Shili, Ho, Paul C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032105/ https://www.ncbi.nlm.nih.gov/pubmed/32104380 http://dx.doi.org/10.1016/j.ajps.2017.09.001 |
Ejemplares similares
-
Preparation and characterisation of PHT-loaded chitosan lecithin nanoparticles for intranasal drug delivery to the brain
por: Yousfan, Amal, et al.
Publicado: (2020) -
Preparation of Biocompatible Carboxymethyl Chitosan Nanoparticles for Delivery of Antibiotic Drug
por: Zhao, Liang, et al.
Publicado: (2013) -
Development of Carbamazepine Nanostructured Lipid Carrier Loaded Thermosensitive Gel for Intranasal Delivery
por: Deshkar, Sanjeevani Shekhar, et al.
Publicado: (2021) -
Data on enrichment of chitosan nanoparticles for intranasal delivery of oligonucleotides to the brain
por: Sava, Vasyl, et al.
Publicado: (2020) -
Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy
por: Gulati, Neha, et al.
Publicado: (2013)